Pay in 4 interest-free payments of $5.50 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
AOD-9604 progressed through six human clinical trials with more than 900 participants but failed to reach statistical significance in its Phase IIb obesity endpoint, and Metabolic Pharmaceuticals terminated development in 2007
Pharmacological treatments are reserved for specific circumstances and limited to licensed medications with demonstrated efficacy and safety profiles, such as orlistat or semaglutide (NICE TA875)
Detectable peptide fragments may persist in the urine for a few days (2)
Such as kisspeptin (a gonadotrophin releasing hormone analog for reproductive health, promoted for increasing libido) and KPV, lysine-proline-valine, an alpha melanocyte-stimulating hormone, with purported anti-inflammatory and wound healing effects
US$ 26.67
US$ 24.34
US$ 29.60
US$ 21.20
US$ 20.38
US$ 26.31
